Diseases like Alzheimer’s, Parkinson’s and Huntington’s slowly destroy the brain’s nerve cells. When these cells disappear, people lose memory, have trouble thinking and may find it hard to move.
Today’s medicines can ease some symptoms, but they cannot bring back lost brain cells. Researchers are now looking for ways to help the brain grow new neurons.
A Vitamin Known for Blood and Bones
Vitamin K is famous for helping blood clot and keeping bones strong. Recent studies also link it to protecting brain cells and helping immature cells turn into working neurons.
The natural form called menaquinone‑4 (MK‑4) does help, but its effect is too weak for big brain‑repair projects.
Making Vitamin K More Powerful
A Japanese team at Shibaura Institute of Technology created 12 new vitamin K‑like molecules. Some were joined with retinoic acid, a form of vitamin A that is known to push stem cells toward becoming neurons.
These hybrid compounds kept the good parts of both vitamins. In mouse stem cells, one special molecule – called “Novel VK” – was three times better at making neurons than regular vitamin K.
How the New Compound Works
Scientists discovered that vitamin K talks to the brain through a receptor called mGluR1. This receptor helps cells change their genes so they become neurons.
Computer models showed that Novel VK fits into mGluR1 even better than MK‑4. Inside cells, Novel VK turned into MK‑4 quickly, raising the amount of active vitamin K in the brain.
From Cells to Mice
When mice received Novel VK, the drug stayed in the body for a long time, crossed the blood‑brain barrier, and raised brain levels of MK‑4 more than the natural vitamin.
Why This Matters
If a pill can push stem cells to become neurons, it could become a new type of treatment that does more than just slow symptoms. It might one day help replace lost brain cells in Alzheimer’s, Parkinson’s and similar illnesses.
Right now the work is still in cells and mice. Human trials are needed before any vitamin K drug can be used for brain repair.
Looking Ahead
Scientists are excited because the study points to a clear target – the mGluR1 pathway – for future drugs. A safe, effective vitamin K‑based therapy could improve lives and lower the huge cost of caring for people with neuro‑degenerative diseases.